North America expected to continue its highest share in miRNA Sequencing and Assay Market | Research Cosmos

North America miRNA Sequencing And Assays Market Size and Growth Rate:

The North America miRNA sequencing and assays market is forecasted to reach USD 341.0 million by 2024 from USD 181.0 million in 2018, at a CAGR of 11.0%.

Browse 120 Pages of Research Report developed on North America miRNA Sequencing And Assays Market @ https://www.researchcosmos.com/reports/north-america-mirna-sequencing-and-assay-market/98024551

North America miRNA Sequencing And Assays Market Growth Drivers and Restraints:

The miRNA sequencing and assays market is driven by several factors such as the benefits of miRNA sequencing over other technologies, increasing research funding for genomics, and the reducing cost of sequencing. But, the dearth of skilled professionals is expected to limit market growth to a certain extent.

Although the factors such as the superiority of miRNA sequencing over other techniques coupled with a significant reduction in the cost of sequencing are making the North American miRNA sequencing and assay market,the threat of potential artifacts error and high-cost infrastructure requirements are projected to restrain the market growth.

For Free Sample @ https://www.researchcosmos.com/request/north-america-mirna-sequencing-and-assay-market/98024551

The sequencing by synthesis segment commanded the market with the largest share in 2018 due to the technological improvements in sequencing platforms and the decreased costs. Sequencing consumables ruled the market with a larger share in 2018. The large share of this segment can essentially be attributed to the repeat purchases of kits due to their special requirement and the high costs compared to library preparation kits. In 2017, academic and research institutes accounted for the highest share of the miRNA sequencing & assays market. The large share of this section can be attributed to the availability of research grants and the growing focus of market players on providing efficient miRNA sequencing products and help for research applications.

North America miRNA Sequencing And Assays Market Geographical Segmentation:

North America accounted for the largest share of the market in 2018. Factors such as growing investments in the development of sequencing, developing research in the fields of genomics and RNA biology, and the growing demand for economical, high-throughput techniques for miRNA analysis are encouraging the growth of the market in this region.

Illumina, a leading player in the market, gives an extensive product portfolio of miRNA sequencing kits and assays. It has a notable presence in more than 100 nations including major markets such as Germany, US, China, and Japan. Illumina focuses on natural and inorganic growth strategies such as companies and collaborations to remain competitive in the market. In the latest three years, it collaborated with several organizations such as BioRad (US) and Thermo Fisher Scientific (US) as well as included a new, smaller, and cheaper NGS programs such as the iSeq 100.

Key Players of the North America miRNA Sequencing And Assays Market:

The North American miRNA sequencing and assays market include main players such as Illumina (US), Thermo Fisher Scientific (US), and BioRad (US), among others.

For Any Queries Inquire More @ https://www.researchcosmos.com/inquire/north-america-mirna-sequencing-and-assay-market/98024551

About Us:

Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.

Contact:

Kevin Stewart

Global Sales Manager

Research Cosmos

www.researchcosmos.com

 

June 11, 2019
by @researchcosmos
0
1
Market Research

MEA Reporter Gene Assay Market expected to cross USD 2.6 billion by 2024 | Research Cosmos

Middle East and Africa Reporter Gene Assay Market Size and Growth Rate:

The Middle East and Africa (MEA) reporter gene assays market is projected to reach USD 2.6 billion by 2024 from USD 1.6 billion in 2018, at a CAGR of 10.1%.

Browse 120 Pages of Research Report developed on Middle East and Africa Reporter Gene Assay Market @ https://www.researchcosmos.com/reports/middle-east-and-africa-reporter-gene-assay-market/98191201

Middle East and Africa Reporter Gene Assay Market Growth Drivers and Restraints:

The market is anticipated to grow in the forecast period owing to driving factors such as rising on account of advancements, increasing funding for cell-based research, growing applications of gene expressions and a rising preference for cell-based assays. Nevertheless, the high cost of cell biology research is expected to restrict the market in the MEA during the forecast period. 

The demand within the regional reporter gene assay market has been rising on account of advancements in the field of molecular biology. The study of genes and protein structures is a key area of study within molecular biology, and several experiments and researches have been conducted in this regard. Furthermore, the need for a seamless industry for gene sequencing has also aided market growth. There is a high possibility of new revenues flowing into the MEA reporter gene assay market in the years to come.

For Free Sample @ https://www.researchcosmos.com/request/middle-east-and-africa-reporter-gene-assay-market/98191201

Middle East and Africa Reporter Gene Assay Market Geographical Segmentation:

The MEA market has been expanding at a stellar pace in recent times. The presence of a sound domain for genetics within molecular biology has played a vital role in market growth. Moreover, the study of genetic diseases in animals and humans is can also be initiated and accomplished with the help of market. The need for selectable markers in gene therapy studies is amongst the most prominent drivers of demand within the regional market. The possibility of using reporter gene assay in DNA constructs has also increased in recent times.

KeyPlayers of the Middle East and Africa Reporter Gene Assay Market:

The prominent players in the MEA reporter gene assays market are Merck KGaA, Thermo Fisher Scientific, Promega Corporation, PerkinElmer, Biotium, Abcam plc, Bio-Rad Laboratories, Becton, Dickinson and Company, Danaher Corporation, Geno Technology, Genecopoeia, InvivoGen, and PromoCell.

For Any Queries Inquire More @ https://www.researchcosmos.com/inquire/middle-east-and-africa-reporter-gene-assay-market/98191201

About Us:

Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.

Contact:

Kevin Stewart

Global Sales Manager

Research Cosmos

www.researchcosmos.com

 

June 11, 2019
by @researchcosmos
0
1
Market Research

Packaged system was the highest contributor to the MEA Medical Equipment Cooling Market | Research Cosmos

Middle East and Africa Medical Equipment Cooling Market Size and Growth Rate:

The Middle East and Africa (MEA) medical equipment cooling market is projected to increase from an estimated USD 176.64 million in 2018 to USD 235.62 million by 2026, at a CAGR of 3.65% during the forecast period.

Browse 120 Pages of Research Report developed on Middle East and Africa Medical Equipment Cooling Market @ https://www.researchcosmos.com/reports/middle-east-and-africa-medical-equipment-cooling-market/23647506

Middle East and Africa Medical Equipment Cooling Market Growth Drivers and Restraints:

The MEA medical equipment cooling market is expected to grow in the forecast period owing to factors such as increasing geriatric population, the growing prevalence of cancer, and a growing number of diagnostic centers & hospitals. But economic benefits offered by medical equipment cooling technological improvements in diagnostic imaging modalities is expected to offer more growth opportunities for the players working in the market.

The MEA medical equipment cooling market is expected to witness tremendous growth during the forecast period. The report provides important statistics on the market status of the leading market professionals and offers key trends and opportunities in the market.Growth of the MEA market is largely driven by the economic benefits offered by cooling systems, increasing incidence of cancer and other diseases, and growing geriatric population.

For Free Sample @ https://www.researchcosmos.com/request/middle-east-and-africa-medical-equipment-cooling-market/23647506

Glen Dimplex is the best player in the medical equipment cooling systems market. The company manufactures and distributes a wide range of chillers and cooling solutions over the medical, food packaging, plastics, and semiconductor manufacturers internationally. It offers active and quiet cooling solutions either in integrated or stand-alone modes, for a full range of medical equipment such as linear accelerators, CT, MRI, land medical laser technology. The company has an MEA presence and a prominent after-sales service network, with locations in different areas of the world.

Middle East and Africa Medical Equipment Cooling Market Geographical Segmentation:

The MEA region is one of the main revenue-generating regions in the world medical equipment cooling market. Saudi Arabia, UAE, and Nigeria are the major countries responsible for the tremendous growth of this regional market due to factors such as the growing awareness of optimal thermal management of medical equipment, rise in healthcare expenditure, and rising geriatric population.

KeyPlayers of the Middle East and Africa Medical Equipment Cooling Market:

The Key players in the MEA medical equipment cooling market are Legacy Chiller Systems Inc., Glen Dimplex Group, and Filtrine Manufacturing Company, Inc. Other important players in this market include Cold Shot Chillers, KKT Chillers, Laird Technologies, Inc., General Air Products, Inc., Lytron, Inc., Motivair Corporation, Drake Refrigeration, Inc., American Chillers, Whaley Products Inc., Johnson Thermal Systems, Parker Hannifin Corp and Haskris, among others.

For Any Queries Inquire More @ https://www.researchcosmos.com/inquire/middle-east-and-africa-medical-equipment-cooling-market/23647506

About Us:

Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.

Contact:

Kevin Stewart

Global Sales Manager

Research Cosmos

www.researchcosmos.com

June 11, 2019
by @researchcosmos
0
1
Market Research
Healthcare

Increase in demand from hospitals reinforces Latin America Radiation Protection Apron Market | Research Cosmos

Latin America Radiation Protection Apron Market Size and Growth Rate:

The Latin American medical radiation protection aprons market is projected to reach USD 48.0 million by 2025 from USD 35.0 million in 2018, at a CAGR of 6.60% during the projection period.

Browse 120 Pages of Research Report developed on Latin America Radiation Protection Apron Market @ https://www.researchcosmos.com/reports/latin-america-radiation-protection-apron-market/37865198

Latin America Radiation Protection Apron Market Growth Drivers and Restraints:

Increase in demand for radiation protection aprons in hospitals, development, and advancement in these products, and rise in diagnostic centers drive the Latin American market. Other drivers include technological improvements in radiation protection apron and high or sudden rise in the number of events and patient hospitalizations. Major restraints of the market are the development of other substitute technologies and strong competition among existing manufacturers. Moreover, product recalls, government regulations for reduction of overall health care cost, and subsequent increase in the bulk purchase through group purchasing organizations hamper the market growth.

The regional market is driven by factors such as an increase in a number of medical imaging processes, coupled with the increase in the technological advancements in anti-radiation clothing. Also, growing awareness among professionals and technical personnel, and rise in the implementation of radiation guidelines in organizations is estimated to drive the growth of the Latin American market.

Trained radiologic technologists are needed for the effective operation of medical imaging equipment, such as X-ray and computed tomography (CT), which are broadly used for diagnostic and treatment applications in hospitals and other healthcare amenities. The increase in the number of radiologic technologists is anticipated to have a direct impact on the growth of the medical radiation protection aprons market.

For Free Sample @ https://www.researchcosmos.com/request/latin-america-radiation-protection-apron-market/37865198

Increasing safety awareness among people working in or around radiation prone area and increasing technological advancements in radiologic technologists are the two main constituents which are expected to feed the market for these aprons in LATAM. Leniency in practicing lead aprons during dental x-ray procedures could be a possible restraint which can impede the growth rate of the market.

Latin America Radiation Protection Apron Market Geographical Segmentation:

Latin America is estimated to be the fastest growing region in the world market due to the improved adoption of technology in the area of protective clothing. Also, various companies are focusing on this region for expansion due to low labor costs and the abundant availability of raw resources.

KeyPlayers of the Latin America Radiation Protection Apron Market:

The Latin American market is highly competitive due to the presence of numerous international and regional players. Key organizations operating in the local market are Infab Corporation, Bar-Ray Products, Shielding International, Inc., AliMed, Inc., Kiran, Burlington Medical,Amray Radiation Protection, and Protech Medical.

For Any Queries Inquire More @ https://www.researchcosmos.com/inquire/latin-america-radiation-protection-apron-market/37865198

About Us:

Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.

Contact:

Kevin Stewart

Global Sales Manager

Research Cosmos

www.researchcosmos.com

 

June 11, 2019
by @researchcosmos
0
1
Market Research
Healthcare

Innovations in drug delivery support Europe Pharmaceutical Packaging Equipment Market | Research Cosmos

Europe Pharmaceutical Packaging Equipment Market Size and Growth Rate:

The Europe pharmaceutical packaging equipment market is forecasted to reach USD 1.91 billion by 2021 from USD 1.35 billion in 2016, at a CAGR of 6.71%.

Browse 120 Pages of Research Report developed on Europe Pharmaceutical Packaging Equipment Market @ https://www.researchcosmos.com/reports/europe-pharmaceutical-packaging-equipment-market/19721317

Europe Pharmaceutical Packaging Equipment Market Growth Drivers and Restraints:

Growing demand for flexible and integrated packaging, increasing incidence of diseases, innovations in drug delivery techniques and fast growth of the pharmaceutical industry are some of the key circumstances driving the growth for Europe pharmaceutical packaging equipment market. In addition, growing generic and contract manufacturing activities are expected to hit the market demand. But, high packaging cost, strict environmental and political standards and high competition between the market players are some of the major circumstances restraining the growth of the regional market.

Rising demographics and economies in developing countries of Europe would lead to an increase in pharmaceutical packaging equipment market in this region. In addition, the growing demand for primary pharmaceutical containers would receive an opportunity for this market. But changing health regulations and availability and cost volatility of raw material could be a challenge for the European market. Companies included in pharmaceutical packaging have been involved in saving the operational value. In addition, the rising number of mergers and acquisitions, new product launches and a growing number of collaborations and communities are some of the trends that have been observed in the local market.

Pharmaceutical packaging equipment presents safety and quality of packaging for pharmaceutical products. Unlike conventional packaging systems, the material used nowadays are modern, adaptable, automated and are combined to meet pharmaceutical products requirements. Pharmaceutical packaging equipment helps in reducing the time for the packaging of goods that helps to improve production and innovations in drug delivery systems and personalized drugs.

For Free Sample @ https://www.researchcosmos.com/request/europe-pharmaceutical-packaging-equipment-market/19721317

Europe Pharmaceutical Packaging Equipment Market Geographical Segmentation:

Robert Bosch is one of the leading suppliers of various technologies and services in Europe. The company is involved in the manufacturing, marketing, and distribution of a type of mobility and industrial technology solutions, such as energy and control technologies; packaging technologies; and customer goods & energy and building technology solutions. Furthermore, The company sales and service associates in around 150 nations across Africa, the Americas,Europe, Asia, Australia, and the Middle East.

Key players of the Europe Pharmaceutical Packaging Equipment Market:

The leading players in the Europe pharmaceutical packaging equipment market are Robert Bosch (Germany), Körber (Germany),Marchesini Group (Italy), IMA (Italy), MG2 (Italy), Uhlmann Group (Germany), Romaco Holding (Germany), Bausch + Ströbel (Germany),OPTIMA Packaging Group (Germany), Coesia (Italy), and MULTIVAC Group (Germany).

For Any Queries Inquire More @ https://www.researchcosmos.com/inquire/europe-pharmaceutical-packaging-equipment-market/19721317

About Us:

Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.

Contact:

Kevin Stewart

Global Sales Manager

Research Cosmos

www.researchcosmos.com

June 11, 2019
by @researchcosmos
0
1
Market Research

Europe Biosimilars Market expected to cross USD 11.6 Million by 2024 | Research Cosmos

Europe Biosimilars Market Size and Growth Rate:

The biosimilar market in Europe relinquished a value of US$ 2,934.60 Million in 2018. The market is further forecasted to reach US$ 11,663.10 Million by 2024, increasing at a CAGR of 32.35% during 2019-2025.

Browse 140 Pages of Research Report developed on Europe Biosimilars Market @ https://www.researchcosmos.com/reports/europe-biosimilars-market/92169510

Europe Biosimilars Market Overview:

The European biosimilar market outlines the most mature in the world and remains to rally momentum. This market is expected to increase robustly in the next five years, as a number of blockbuster biologics are programmed to lose patent protection in Europe.

Biosimilars are biotherapeutic results, which are similar to previously licensed reference biologics, in terms of feature, safety, and efficiency. Biosimilar manufacturers wait till the control of the reference product expires and then seek permission from the regulatory authorities in order to provide their biosimilar versions. These companies use the state-of-the-art technology for comparing the features, such as purity, chemical identity, and bioactivity, of the proposed biosimilar to its source product.

Europe Biosimilars Market Growth Drivers and Restraints:

Along with the cost-effectiveness of biosimilar drugs, the high prevalence of chronic disorders is also a significant factor contributing to the success of this region, and the continued market growth is seen. As numbers of individuals with cancer, diabetes, anemia and other chronic diseases continue to increase, there is a high demand for cost-effective biosimilar drugs to treat these conditions.

Biosimilars are less valuable than their branded counterparts as they do not require large research and testing which saves both money and time; thereby reducing the costs. Furthermore, they also have short marketing times as beginning a biosimilar does not require extensive marketing as the safety and effectiveness profile of their branded counterparts have already been established.

Several blockbuster biologics are anticipated to lose their patent security over the next 5 to 10 years. This expiration of patents and other intellectual property claims is anticipated to create huge possibilities for biosimilar manufacturers.

For Free Sample @ https://www.researchcosmos.com/request/europe-biosimilars-market/92169510

Europe Biosimilars Market Geographical Segmentation:

The European population is aging with around one-fifth of the total EU population above 65 years of age. This will create significant increase in the burden of lifestyle disorders in the region. The prevalence of diseases such as diabetes, autoimmune disorders, oncology, etc. has been growing rapidly in Europe. This is also expected to drive market growth during the next few years.

As a result of increasing healthcare costs, governments across a number of European nations have formulated policies incentivizing physicians, pharmacists, and patients in favor of biosimilars over branded biologics.

Key Players of the Europe Biosimilars Market:

The Major Players in the European Biosimilars Market include Novartis, Pfizer, Teva, Celltrion, Samsung Bioepis, Amgen, Apotex, Ratiopharm, Mylan, Merck Sharp & Dohme, Eli Lilly, Accord Healthcare Ltd, Boehringer Ingelheim, Hexal Ag, StadaArzneimittel Ag.

For Any Queries Inquire More @ https://www.researchcosmos.com/inquire/europe-biosimilars-market/92169510

About Us:

Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.

Contact:

Kevin Stewart

Global Sales Manager

Research Cosmos

www.researchcosmos.com

June 11, 2019
by @researchcosmos
0
1
Market Research
Healthcare
Show more